Today's Top Gainer
SYMBOL | CMP | Chg (%) |
---|---|---|
Note:Top Gainer - Nifty 50 More
Dr. Lal PathLabs Q2 PAT up 41.48% at Rs 80.50 cr
Nov 09,2019 12:43 PM
Dr. Lal PathLabs recorded 41.48% jump in consolidated profit after tax to Rs 80.50 crore on 15.15% increase in revenues to Rs 365.
Dr Lal Pathlabs consolidated net profit rises 41.48% in the September 2019 quarter Nov 09,2019
Board of Dr. Lal PathLabs recommends Interim Dividend Nov 09,2019
Dr Lal Pathlabs Ltd leads losers in A group Nov 01,2019
Dr. Lal PathLabs to hold board meeting Oct 19,2019
Dr. Lal Pathlabs to acquire 70% stake in new co. to strengthen presence in Gujarat Oct 01,2019
Meeting Type
Meeting Date
Resolution Type | Description Of Resolution | IiAS Recommendation |
---|
Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd | 1,390.45 | 58.10 | 19,373.16 | 90.60 | 0.43 | 2,463.58 | 266.78 |
Dr Lal Pathlabs Ltd | 1,548.25 | 56.65 | 12,866.28 | 79.50 | 0.39 | 351.20 | 124.96 |
Fortis Healthcare Ltd | 135.00 | 14.50 | 10,191.94 | -13.27 | 0.00 | 181.40 | 116.85 |
Aster DM Healthcare Ltd | 149.15 | 149.44 | 7,474.84 | -4.34 | 0.00 | 200.60 | 58.79 |
Metropolis Healthcare Ltd | 1,292.40 | 55.59 | 6,502.40 | 31.68 | 1.02 | 172.28 | 92.41 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Dr. Lal PathLabs has built a national, hub and ... More
E-2 Block Sector 18,Rohini,New Delhi, New Delhi,110085
Tell. : +91-011-3024 4149
Website : http://www.lalpathlabs.com
Email : cs@lalpathlabs.com
Noble Heights 1st Fl, LSC Janakpuri, New Delhi - 110058 INDIA
Tell. : +91-11-41410592/93/94
Website : www.linkintime.co.in
Email : delhi@linkintime.co.in
Dec 12, 2019 12:58 AM
The company’s consolidated revenue stood at Rs292.50cr, up 11.34% yoy but down 7.87% qoq.
Purpose
Dividend
Annc. Date
08 Nov 2019
Effective. Date
20 Nov 2019
Divi. Type
Interim
Divi.(%)
60
Divi. Amt.
6
Dr. Lal PathLabs Ltd has informed BSE that the Board of Directors of the Company at its meeting held... More
Purpose
Board Meeting
Exp. Date
08 Nov 2019
Annc. Date
18 Oct 2019
Interim Dividend & Quarterly ResultsDear Sir/Madam,Please take note that the Board of Directors in t... More